FIELD: medicine.
SUBSTANCE: method involves administering hepatoprotector means and transplanting spinal marrow stem cells. The stem cells are selected from aspirated spinal marrow sample taken from the patient. The portion to be introduced is calculated so that the number of CD34-position cells is equal to 40-240x106 cells. Then the portion is divided into two halves of which the first one is intrahepatically introduced, and the second one is intravenously introduced.
EFFECT: enhanced effectiveness of treatment; reduced risk of hepatic cell insufficiency syndrome.
2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| BIOTRANSPLANT, TREATMENT METHOD OF CHRONIC LIVER DISEASES AND TREATMENT METHOD OF LIVER CIRRHOSIS AND PORTAL HYPERTENSION | 2007 |
|
RU2368384C2 |
| BIOTRANSPLANT, METHOD FOR ITS PREPARING AND METHOD FOR TREATMENT OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS (VARIANTS) | 2004 |
|
RU2272638C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS | 2003 |
|
RU2243784C2 |
| METHOD FOR TREATING CHRONIC HEPATITIS | 2005 |
|
RU2282457C1 |
| METHOD FOR TREATING CHRONIC HEPATITISES OR HEPATIC CIRRHOSIS CASES | 2006 |
|
RU2295351C1 |
| CELL PRODUCT FOR TREATING AND CORRECTING HEPATIC IMPAIRMENT | 2012 |
|
RU2510833C1 |
| METHOD FOR REGENERATIVE CELL THERAPY FOR TREATING HEPATOCELLULAR INSUFFICIENCY IN LIVER CIRRHOSIS | 2023 |
|
RU2822653C1 |
| METHOD FOR TREATING CHRONIC DIFFUSE LIVER DISEASES | 1998 |
|
RU2161036C2 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| METHOD FOR TREATING HEPATIC CIRRHOSIS CASES | 2005 |
|
RU2318526C2 |
